Randomised controlled trial of home mechanical ventilation in hypercapnic chronic obstructive pulmonary disease patients post acute hypercapnic exacerbation

Guy's and St. Thomas' NHS Foundation Trust (UK)0 个研究点目标入组 116 人开始时间: 2010年3月31日最近更新: 2017年7月3日

试验速览

暂无简介。

•1. Acute hypercapnic exacerbation of COPD at least 2 weeks previously
•2. In patient admission with acute hypercapnic respiratory failure
•3. Smoking greater than 20 pack year history
•4. Forced expiratory volume in one second (FEV1) less than 50%
•5. FEV1/forced vital capacity (FVC) less than 60%
•6. Chronic hypercapnia (PaCO2 greater than 7 kPa)
•7. Chronic hypoxia PaO2 less than 7.3 kPa or less than 8 kPa with secondary polycythaemia, pulmonary hypertension, peripheral oedema or significant nocturnal hypoxia (SpO2 less than 90% for greater than 30% sleep time)
•8. Aged 18 years or older, either sex

•1. Unable to wean off NIV prior to discharge (persistent hypercapnic respiratory failure with pH less than 7.30)
•2. Post extubation or decanulation
•3. Body mass index (BMI) greater than 35 kg/m^2
•4. Primary diagnosis of restrictive lung disease causing hypercapnia
•5. Development of worsening hypercapnic respiratory failure with acidosis during initiation of oxygen therapy (ABG - pH less than 7.30 taken 2 - 4 hours after waking)
•6. Unable to tolerate NIV (if given) during acute illness
•7. Unstable coronary artery syndrome
•8. Renal replacement therapy
•9. Inability to consent/comply with trial protocol (as determined by site PI)
•10. Aged less than 18 years
•11. Pregnant

发起方

Guy's and St. Thomas' NHS Foundation Trust (UK)